Jiangsu Changlong Chemicals, Co. v. Burlington Bio-Medical & Scientific Corp.

399 F. Supp. 2d 165, 2005 U.S. Dist. LEXIS 29543, 2005 WL 3144071
CourtDistrict Court, E.D. New York
DecidedNovember 22, 2005
DocketCV05-2082
StatusPublished
Cited by5 cases

This text of 399 F. Supp. 2d 165 (Jiangsu Changlong Chemicals, Co. v. Burlington Bio-Medical & Scientific Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jiangsu Changlong Chemicals, Co. v. Burlington Bio-Medical & Scientific Corp., 399 F. Supp. 2d 165, 2005 U.S. Dist. LEXIS 29543, 2005 WL 3144071 (E.D.N.Y. 2005).

Opinion

MEMORANDUM AND ORDER

WEXLER, District Judge.

This is an action commenced by Plaintiff Jiangsu Changlong Chemicals, Co., Inc. (“Changlong”), pursuant to Convention on the Recognition and Enforcement of Foreign Arbitral Awards, 9 U.S.C. § 201 (the “Convention”). Changlong seeks recognition and enforcement of an award made in China after an arbitration in which both parties participated. China is a signatory to the Convention and this court has original jurisdiction over this matter pursuant to 9 U.S.C. § 203. For the reasons set forth below, Changlong’s motion for summary judgment seeking recognition and enforcement of the award is granted.

BACKGROUND

I. The Contracts And The Agreement To Arbitrate

Plaintiff Changlong is a limited liability company, organized under the laws of the People’s Republic of China. Defendant Burlington Bio-Medical & Scientific Corporation (“Burlington”) is a corporation organized pursuant to the laws of the State of New Jersey. Changlong’s principal place of business is in China and that of Burlington is located in this District.

At various times between May and October of 2002, Changlong and Burlington entered into eight contracts (the “Contracts”) for the sale of an insecticide sold under the name “Carbaryl.” Each of the Contracts provided for Changlong to deliver to Burlington a specific quantity of Carbaryl. Each contract set forth specific payment and shipping terms and each contained a clause providing for settlement of any dispute through amicable negotiation. In the event that such negotiation failed to settle any dispute, the Contracts provided that disputes were to be submitted to the China International Economic and Trade Arbitration Commission for resolution through arbitration. The parties to the Contracts agreed that the decision reached after such arbitration was to be final and binding.

II. The Dispute That Led To The Arbitration

There is no dispute regarding delivery of the Carbaryl, pursuant to the Contracts, by Changlong. There is similarly no dispute that Burlington failed to make full and timely payment. Correspondence between the parties indicates that Burlington *167 requested, and Changlong agreed, to several extensions of time in which to make full payment. Burlington made a partial payment of $248,400 due under one of the Contracts. Full payment, however, was never received and Changlong claims to be owed in excess of $1.7 million.

III. The Arbitration And The Award

On August 21, 2003, Changlong initiated arbitration pursuant to the Contracts. Changlong sought $1,775,880 allegedly owed under the Contracts as well as contractual penalty payments in excess of $1.5 million. Changlong also sought arbitration and attorneys’ fees, as provided in the Contracts, and in accord with the applicable procedural rales of arbitration.

On September 5, 2003, the body conducting the arbitration (the “Arbitration Commission” or the “Commission”) sent the parties hereto the arbitration notice, arbitration rales and a list of potential arbitrators. Additionally, Burlington was sent Changlong’s arbitration application as well as a copy of the evidence that Chang-long submitted to the Commission. Changlong selected one arbitrator, but Burlington failed to designate a preferred arbitrator. Accordingly, the Commission selected the remaining two arbitrators that were to serve as the tribunal hearing the parties’ dispute (the “Tribunal”). On October 30, 2003, the parties were mailed notice of the identity of the members of the Tribunal.

The arbitration was set to begin on December 9, 2003. Notice of this date was mailed to Burlington on October 30, 2003. Upon receipt of this notice, Burlington informed the Commission that it was unable to obtain necessary visas to attend the arbitration and the December 9 hearing was adjourned. Thereafter, the Tribunal scheduled the hearing for February 17, 2004.

On February 17, 2004, the arbitration was held. Both Changlong and Burlington designated local Chinese attorneys to appear as their agents at the hearing. As set forth in the arbitration award, these agents participated fully in the proceeding. Each side debated and responded to questions and submitted proposed opinions to the Tribunal.

The final decision of the Tribunal is memorialized in a detailed award that is dated June 23, 2004 (the “Award”). 1 The Award details the terms of the Contracts and Burlington’s numerous requests for extensions of time in which to make payment. The Tribunal noted that full payment was never made and rejected Burlington’s defense that the Carbaryl price was in violation of the parties’ separate “cooperation” agreement. Concluding that Burlington beached its obligations under the Contracts, the Award holds Burlington liable for the $1,775,880 sought by Chang-long. The Award denied Changlong the $1.5 million penalty but granted the request for attorneys’ fees. Finally, the Award held that 20% of the arbitration fee should be borne by Changlong and the remainder was to be paid by Burlington. Burlington was ordered to make payment to Changlong within 45 days of the Award. In the event that such payment was not made, Burlington was to bear an additional interest payment of 6%.

IV. The Present Action And The Motion For Summary Judgment

Burlington’s failure to make any payment under the Award prompted the filing of this lawsuit seeking recognition and enforcement of the Award. The motion presently before the court seeks summary judgment on this single claim.

*168 DISCUSSION

I. Ghvunds for Enforcement of Foreign Arbitral Awards Pursuant to the Convention

Countries that are parties to the Convention, including the United States and China, agree to recognize each other’s arbitral awards and to enforce them in accord with the rules of procedure of the place where the award is relied upon. See Geotech Lizenz AG v. Evergreen Sys., Inc., 697 F.Supp. 1248, 1252 (E.D.N.Y.1988). Conformation of a foreign arbitral award is characterized as a “summary proceeding” that merely converts what is already a final decision into a judgment of a court. MGM Productions Group, Inc. v. Aeroflot Russian Airlines, 2003 WL 21108367 *2 (S.D.N.Y.2003).

The procedure for obtaining enforcement of a foreign award is straightforward. The party seeking enforcement need only submit an authentic copy of the award, the agreement to arbitrate and, if the award is in a language other than English, a duly certified translation. See Convention Art. IV; Geotech, 697 F.Supp. at 1252. Upon submission of these materials, a party resisting confirmation bears the burden of showing that one of the circumstances warranting denial of enforcement, as set forth in the Convention, is present.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
399 F. Supp. 2d 165, 2005 U.S. Dist. LEXIS 29543, 2005 WL 3144071, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jiangsu-changlong-chemicals-co-v-burlington-bio-medical-scientific-nyed-2005.